Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 618

1.

Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions.

Silva EA, Iyer A, Ura S, Lauris JR, Naafs B, Das PK, Vilani-Moreno F.

Trop Med Int Health. 2007 Dec;12(12):1450-8.

2.
3.

Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy.

Iyer A, van Eijk M, Silva E, Hatta M, Faber W, Aerts JM, Das PK.

Clin Immunol. 2009 Jun;131(3):501-9. doi: 10.1016/j.clim.2009.02.003.

PMID:
19307157
4.

Serological monitoring of the response to chemotherapy in leprosy patients.

Roche PW, Britton WJ, Failbus SS, Neupane KD, Theuvenet WJ.

Int J Lepr Other Mycobact Dis. 1993 Mar;61(1):35-43.

PMID:
8326179
5.
6.

Anti-PGL-1 antibody levels in Thai leprosy patients.

Kampirapap K, Singtham N.

Southeast Asian J Trop Med Public Health. 1996 Dec;27(4):728-33.

PMID:
9253875
7.

Cytokines in leprosy, II. Effect of treatment on serum cytokines in leprosy.

Moubasher AD, Kamel NA, Zedan H, Raheem DD.

Int J Dermatol. 1998 Oct;37(10):741-6.

PMID:
9802683
9.

Daily multidrug therapy for leprosy; results of a fourteen-year experience.

de Carsalade GY, Wallach D, Spindler E, Pennec J, Cottenot F, Flageul B.

Int J Lepr Other Mycobact Dis. 1997 Mar;65(1):37-44.

PMID:
9207752
10.

Assessment of anti-PGL-I as a prognostic marker of leprosy reaction.

Stefani MM, Martelli CM, Morais-Neto OL, Martelli P, Costa MB, de Andrade AL.

Int J Lepr Other Mycobact Dis. 1998 Sep;66(3):356-64.

PMID:
9934362
11.

Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.

Meeker HC, Schuller-Levis G, Fusco F, Giardina-Becket MA, Sersen E, Levis WR.

Int J Lepr Other Mycobact Dis. 1990 Sep;58(3):503-11.

PMID:
2205685
12.

Effects of chemotherapy on antibody levels directed against PGL-I and 85A and 85B protein antigens in lepromatous patients.

Drowart A, Chanteau S, Huygen K, De Cock M, Cartel JL, De Bruyn J, Launois P, Yernault JC, Van Vooren JP.

Int J Lepr Other Mycobact Dis. 1993 Mar;61(1):29-34.

PMID:
8326178
13.

Detection of phenolic glycolipid-I antigen and antibody in sera from new and relapsed lepromatous patients treated with various drug regimens.

Cho SN, Cellona RV, Fajardo TT Jr, Abalos RM, dela Cruz EC, Walsh GP, Kim JD, Brennan PJ.

Int J Lepr Other Mycobact Dis. 1991 Mar;59(1):25-31.

PMID:
2030314
15.

Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil.

Hungria EM, Oliveira RM, Penna GO, Aderaldo LC, Pontes MA, Cruz R, Gonçalves HS, Penna ML, Kerr LR, Stefani MM, Bührer-Sékula S.

Infect Dis Poverty. 2016 Dec 6;5(1):110.

16.

IgM antibodies to native phenolic glycolipid-I in contacts of leprosy patients in Venezuela: epidemiological observations and a prospective study of the risk of leprosy.

Ulrich M, Smith PG, Sampson C, Zuniga M, Centeno M, Garcia V, Manrique X, Salgado A, Convit J.

Int J Lepr Other Mycobact Dis. 1991 Sep;59(3):405-15.

PMID:
1890364
17.

Levels of IgG subclasses in active and inactive cases in the disease spectrum of leprosy.

Beuria MK, Parkash O, Joshi B, Mohanty KK, Katoch K, Sengupta U.

Int Arch Allergy Immunol. 1998 Jan;115(1):61-6.

PMID:
9430497
18.

Significance of antibodies to phenolic glycolipid-I in leprosy diagnosis.

Prakash K, Aggarwal R, Sehgal VN.

J Dermatol. 1992 Dec;19(12):953-8.

PMID:
1293187
19.

Evaluation of recombinant serine-rich 45-kDa antigen (ML0411) for detection of antibodies in leprosy patients.

Parkash O, Kumar A, Nigam A, Franken KL, Ottenhoff TH.

Scand J Immunol. 2006 Oct;64(4):450-5.

20.

A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT).

Rada E, Ulrich M, Aranzazu N, Rodriguez V, Centeno M, Gonzalez I, Santaella C, Rodriguez M, Convit J.

Int J Lepr Other Mycobact Dis. 1997 Sep;65(3):320-7.

PMID:
9401484

Supplemental Content

Support Center